Results 101 to 110 of about 4,156,285 (177)

378. Clinical study of PIVKA-II

Japanese Journal of Radiological Technology, 1990
masakazu furukawa, yasuki okumura, tokio endou, kenji takeshima, isao kanamori   +4 more
openaire   +4 more sources

A Clinical Study of the Usefulness of PIVKA-II for the Early Detection of Hepatocellular Carcinoma

A plasma concentration of PIVKA-II was measured in 19 patients with hepatocellular carcinoma (HCC), 44 with liver cirrhosis, 16 with chronic hepatitis, 11 with other benign liver diseases and 10 with other extrahepatic carcinoma.
山城, 章裕, Kinjo, Fukunori, Sakugawa, Hiroshi, 斎藤, 厚, Hirayama, Yoshikatsu, 金城, 福則, Ikema, Minoru, 大湾, 朝尚, Oyakawa, Tominori, Nakayoshi, Tomokuni, Maehara, Nobuto, 親川, 富憲, Ohwan, Tomohisa, Saito, Atushi, 平山, 良克, 佐久川, 廣, 前原, 信人, Yamashiro, Akihiro, 仲吉, 朝邦, 池間, 稔   +19 more
core  

PIVKA II [PDF]

, 2019
openaire   +1 more source

Tissue levels of PIVKA-II and vitamin K in patients with hepatocellular carcinoma. Studies on the mechanism of the production of PIVKA-II.

Kanzo, 1988
OKUNO, Masataka, FUKUTOMI, Yasushi, SHIMAZAKI, Makoto, YAMADA, Tetsuya, MURAKAMI, Nobuo, KAWAI, Kiyoshi, MUTO, Yasutoshi, OMORI, Masahide   +7 more
openaire   +3 more sources

Assessment of the diagnostic performance and influencing factors of AFP and PIVKA-II in hepatocellular carcinoma. [PDF]

Discov Oncol
Wang Y, Liu M, Xie Z, Lin J, Du S, Zhang C, Wang Z, Gao Y.   +7 more
europepmc   +1 more source

Characteristics of Recurrent Hepatocellular Carcinoma Based on Serum AFP, PIVKA-II, and Genetic Mutations. [PDF]

Medicina (Kaunas)
Cho IS, Ahn KS, Jeong S, Kim TS, Kim MJ, Yang SK, Cho S, Kim YH.   +7 more
europepmc   +1 more source

PIVKA-II come nuovo biomarcatore diagnostico nell'adenocarcinoma pancreatico: espressione sierica, tissutale e in vitro [PDF]

Il carcinoma pancreatico è la settima causa principale di decessi cancro correlati a livello globale, con un tasso medio di sopravvivenza a 5 anni di solo il 4%.
TARTAGLIONE, SARA
core  

Prediction of microvascular invasion and post-resection prognosis using ADV, AFP-PIVKA-II, and MoRAL scores in hepatocellular carcinoma patients: an international multicenter cohort study with 9,061 patients. [PDF]

Ann Surg Treat Res
Choi M, Hwang S, Kaibori M, Jo M, Collaboration of Korean Association of Hepato-Biliary-Pancreatic Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery.   +5 more
europepmc   +1 more source

PIVKA-II concentrations in patients with cystic fibrosis. [PDF]

Journal of Clinical Pathology, 1992
E A Cornelissen, A F van Lieburg, C G van Oostrom, L Monnens   +3 more
openaire   +1 more source

Performance Assessment of μTASWako i50, a New Microfluidic Immunoassay System for Hepatocellular Carcinoma Biomarkers AFP, AFP-L3%, and PIVKA-II. [PDF]

Cureus
Yoshikawa T, Ohtsubo T, Yamaguchi I, Nishihara H, Mori Y, Yamada H, Toyoda H, Kawabata T, Matsuda S.   +8 more
europepmc   +1 more source